Table 4 Health impact assessment for PM2.5 (stroke by age).
Adults | Mortality; Stroke for adults | Study year | |||||
|---|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | ||
25–29 years | Estimated Attributable Proportion | 45.99% (34.15–56.82%) | 46.3% (34.47–57.11%) | 39.96% (28.14–51.81%) | 44.09% (32.2-55.05%) | 43.54% (31.66–54.55%) | 46.91% (35.11–57.66%) |
Estimated number of Attributable Cases | 4 (3–5) | 1 (1–2) | 2 (1–3) | 2 (1–2) | 0 (0–1) | 2 (1–2) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 0.87 (0.65–1.08) | 0.38 (0.28–0.47) | 0.58 (0.41–0.75) | 0.55(0.40–0.68) | 0.15 (0.11–0.18) | 0.68 (0.51–0.84) | |
RR (Lower-Upper) | 1.852 (1.519–2.316) | 1.862 (1.526–2.332) | 1.666 (1.392–2.075) | 1.789 (1.475–2.225) | 1.771 (1.463-2.200) | 1.884 (1.541–2.362) | |
30–34 years | Estimated Attributable Proportion | 43.84% (32.63–54.51%) | 44.15% (32.93–54.74%) | 37.92% (26.63–49.9%) | 41.97% (30.78–53.01%) | 41.43% (30.22–52.57%) | 44.75% (33.5-55.18%) |
Estimated number of Attributable Cases | 1 (1–2) | 4 (3–4) | 3 (2–3) | 6 (4–7) | 2 (2–3) | 3 (2–3) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 0.37 (0.27–0.46) | 0.87 (0.65–1.08) | 0.66 (0.46–0.86) | 1.45 (1.06–1.83) | 0.52 (0.38–0.65) | 0.70 (0.52–0.86) | |
RR (Lower-Upper) | 1.781 (1.484–2.198) | 1.791 (1.491–2.209) | 1.611 (1.363–1.996) | 1.723 (1.445–2.128) | 1.707 (1.433–2.108) | 1.8099 (1.504–2.231) | |
35–39 years | Estimated Attributable Proportion | 41.69% (31.48–51.54%) | 42% (31.78–51.79%) | 35.91% (25.74–45.99%) | 39.87% (29.68–49.66%) | 39.34% (29.16–49.09%) | 42.58% (32.36–52.26%) |
Estimated number of Attributable Cases | 1 (1–2) | 6 (5–8) | 4 (3–6) | 4 (3–5) | 4 (3–4) | 4 (3–5) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 0.45 (0.34–0.56) | 1.96 (1.48–2.41) | 1.28 (0.92–1.64) | 1.11 (0.83–1.39) | 0.94 (0.70–1.18) | 1.09 (0.83–1.34) | |
RR (Lower-Upper) | 1.715 (1.459–2.063) | 1.724 (1.466–2.074) | 1.560 (1.347–1.851) | 1.663 (1.422–1.987) | 1.648 (1.412–1.964) | 1.742 (1.478–2.095) | |
40–44 years | Estimated Attributable Proportion | 39.38% (29.16–48.33%) | 39.68% (29.45–48.6%) | 33.76% (23.67–43.36%) | 37.6% (27.44-46.785) | 37.08% (26.95–46.37%) | 40.25% (30-49.13%) |
Estimated number of Attributable Cases | 5 (3–6) | 7 (5–8) | 4 (3–6) | 9 (7–12) | 4 (3–5) | 8 (6–10) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 2.09 (1.55–2.57) | 2.94 (2.18–3.61) | 1.82 (1.28–2.34) | 3.66 (2.67–4.56) | 1.35 (0.98–1.69) | 2.67 (1.99–3.26) | |
RR (Lower-Upper) | 1.649 (1.412–1.936) | 1.658 (1.417–1.946) | 1.509 (1.310–1.765) | 1.603 (1.378–1.879) | 1.589 (1.369–1.865) | 1.674 (1.429–1.966) | |
45–49 years | Estimated Attributable Proportion | 37.23% (28.04–45.52%) | 37.52% (28.33–45.77%) | 31.82% (22.75–40.63%) | 35.51% (26.3-43.92%) | 35.01% (25.81–43.44%) | 38.07% (28.87–46.29%) |
Estimated number of Attributable Cases | 6 (4–7) | 9 (7–11) | 13 (9–17) | 9 (6–11) | 7 (5–8) | 10 (8–12) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 3.26 (2.46–3.99) | 4.49 (3.39–5.48) | 6.69 (4.79–8.55) | 4.25 (3.14–5.25) | 3.25 (2.39–4.03) | 4.77 (3.62–5.80) | |
RR (Lower-Upper) | 1.593 (1.389–1.836) | 1.600 (1.395–1.844) | 1.467 (1.294–1.684) | 1.551 (1.357–1.783) | 1.539 (1.348–1.768) | 1.615 (1.406–1.862) | |
50–54 years | Estimated Attributable Proportion | 34.68% (26.69–43.05%) | 34.96% (26.98–43.27%) | 29.53% (21.46–38.57%) | 33.05% (25-41.61%) | 32.57% (24.51–41.2%) | 35.48% (27.54–43.7%) |
Estimated number of Attributable Cases | 11 (9–14) | 12 (9–14) | 11 (8–14) | 7 (5–9) | 12 (9–16) | 16 (13–20) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 7.16 (5.51–8.89) | 7.47 (5.77–9.25) | 6.87 (4.99–8.97) | 4.50 (3.40–5.66) | 7.41 (5.58–9.38) | 9.33 (7.24–11.49) | |
RR (Lower-Upper) | 1.531 (1.364–1.756) | 1.537 (1.369–1.763) | 1.419 (1.273–1.628) | 1.494 (1.333–1.713) | 1.483 (1.325–1.701) | 1.5499 (1.3799–1.776) | |
55–59 years | Estimated Attributable Proportion | 23.92% (16-31.98%) | 24.1% (16.19–32.15%) | 20.53% (12.7-28.69%) | 22.86% (14.92–31.01%) | 22.55% (14.61–30.73%) | 24.44% (16.56–32.48%) |
Estimated number of Attributable Cases | 8 (5–11) | 13 (9–17) | 13 (8–18) | 10 (6–13) | 9 (6–13) | 16 (11–22) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 6.81 (4.55–9.10) | 9.63 (6.47–12.85) | 9.24 (5.71–12.91) | 7.17 (4.68–9.73) | 6.81 (4.42–9.29) | 11.63 (7.88–15.45) | |
RR (Lower-Upper) | 1.314 (1.191–1.470) | 1.318 (1.193–1.474) | 1.258 (1.145–1.402) | 1.296 (1.175–1.449) | 1.291 (1.171–1.444) | 1.323 (1.198–1.481) | |
60–64 years | Estimated Attributable Proportion | 29.9% (22.51–36.79%) | 30.15% (22.75–37.03%) | 25.22% (18.03–32.61%) | 28.4% (21.1-35.34%) | 27.97% (20.69–34.99%) | 30.63% (23.21–37.5%) |
Estimated number of Attributable Cases | 19 (15–24) | 20 (15–24) | 20 (14–26) | 23 (17–28) | 19 (14–24) | 31 (24–38) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 25.27 (19.02–31.08) | 19.90 (15.01–24.44) | 19.62 (14.02–25.36) | 21.02 (15.61–26.15) | 17.39 (12.86–21.75) | 26.16 (19.82–32.02) | |
RR (Lower-Upper) | 1.427 (1.290–1.582) | 1.432 (1.294–1.588) | 1.337 (1.219–1.484) | 1.397 (1.267–1.547) | 1.388 (1.261–1.538) | 1.442 (1.302-1.600) | |
65–69 years | Estimated Attributable Proportion | 27.54% (20.81–34.55%) | 27.77% (21.04–34.78%) | 23.16% (16.53–30.27%) | 26.13% (19.41–33.13%) | 25.73% (19-32.75%) | 28.22% (21.47–35.21%) |
Estimated number of Attributable Cases | 14 (11–18) | 21 (16–26) | 16 (11–21) | 26 (19–33) | 26 (20–34) | 36 (27–45) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 26.77 (20.23–33.59) | 39.81 (30.16–49.87) | 23.51 (16.79–30.74) | 34.80 (25.84–44.11) | 34.97 (25.83–44.52) | 44.62 (33.94–55.66) | |
RR (Lower-Upper) | 1.379 (1.263–1.528) | 1.384 (1.266–1.533) | 1.301 (1.198–1.434) | 1.354 (1.241–1.495) | 1.346 (1.235–1.487) | 1.393 (1.273–1.543) | |
70–74 years | Estimated Attributable Proportion | 24.69% (18.79–31.25%) | 24.91% (19-31.47%) | 20.62% (14.81–27.07%) | 23.38% (17.5-29.81%) | 23% (17.13–29.42%) | 25.34% (19.42–31.9%) |
Estimated number of Attributable Cases | 20 (15–26) | 29 (22–37) | 15 (11–20) | 20 (15–25) | 19 (14–24) | 26 (20–32) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 46.52 (35.39–58.87) | 62.60 (47.75–79.09) | 33.40 (23.99–43.86) | 42.84 (32.07–54.63) | 43.52 (32.41–55.67) | 57.47 (44.04–72.34) | |
RR (Lower-Upper) | 1.328 (1.231–1.455) | 1.332 (1.235–1.459) | 1.259 (1.174–1.371) | 1.305 (1.212–1.425) | 1.299 (1.207–1.417) | 1.339 (1.241–1.468) | |
75–79 years | Estimated Attributable Proportion | 21.84% (15.92–27.8%) | 22.04% (16.11–27.97%) | 18.15% (12.46–24.44%) | 20.65% (14.76–26.75%) | 20.3% (14.43–26.47%) | 22.43% (16.46–28.3%) |
Estimated number of Attributable Cases | 18 (13–23) | 24 (17–30) | 19 (13–26) | 26 (19–34) | 20 (14–26) | 29 (21–37) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 54.50 (39.74–69.38) | 73.88 (53.99–93.76) | 57.30 (39.34–77.17) | 72.68 (51.97–94.17) | 55.60 (39.53–72.48) | 82.11 (60.24-103.58) | |
RR (Lower-Upper) | 1.279 (1.189–1.385) | 1.283 (1.192–1.388) | 1.222 (1.142–1.323) | 1.260 (1.173–1.365) | 1.255 (1.169–1.3599) | 1.289 (1.197–1.395) | |
80–84 years | Estimated Attributable Proportion | 19.22% (14.03–24.25%) | 19.4% (14.2-24.41%) | 15.94% (10.93–21.4%) | 18.16% (13.03–23.35%) | 17.85% (12.74–23.1%) | 19.75% (14.54–24.71%) |
Estimated number of Attributable Cases | 21 (15–26) | 31 (23–39) | 19 (13–25) | 25 (18–32) | 22 (16–29) | 25 (18–31) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 109.83 (80.17-138.59) | 123.63 (90.50-155.55) | 73.06 (50.12–98.09) | 100.41 (72.06-129.14) | 103.82 (74.11-134.33) | 114.96 (84.63-143.88) | |
RR (Lower-Upper) | 1.238 (1.163–1.320) | 1.241 (1.166–1.323) | 1.189 (1.123–1.272) | 1.222 (1.1498–1.305) | 1.217 (1.146-1.300) | 1.246 (1.170–1.328) | |
+ 85 years | Estimated Attributable Proportion | 16.32% (12.21–20.87%) | 16.47% (12.37–21.03%) | 13.44% (9.53–17.88%) | 15.38% (11.3-19.87%) | 15.11% (11.04–19.59%) | 16.78% (12.68–21.34%) |
Estimated number of Attributable Cases | 22 (16–28) | 32 (24–41) | 20 (14–27) | 26 (19–34) | 26 (19–34) | 33 (25–42) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 152.87 (114.40-195.58) | 166.42 (124.95–212.50) | 94.68 (67.11-125.97) | 108.91 (80.01-140.72) | 131.61 (96.14-170.62) | 175.12 (132.31-222.75) | |
RR (Lower-Upper) | 1.195 (1.139–1.264) | 1.197 (1.141–1.266) | 1.155 (1.105–1.218) | 1.182 (1.127–1.248) | 1.178 (1.124–1.244) | 1.202 (1.145–1.271) | |